iNOS Posttranslational Regulation in Cardiac Rejection

心脏排斥反应中 iNOS 的翻译后调节

基本信息

  • 批准号:
    7579150
  • 负责人:
  • 金额:
    $ 36.78万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-03-15 至 2011-02-28
  • 项目状态:
    已结题

项目摘要

Nitric oxide (NO) production from inducible NO synthase (iNOS) plays an important role in the inflammatory response of cardiac transplant rejection. While iNOS is regulated transcriptionally, the role of posttranslational regulation of iNOS activity in acute rejection is unknown. HYPOTHESIS: Posttranslational factors alter the production of NO from iNOS and determine the downstream actions of NO in acute cardiac rejection. METHODS: Lewis (isograft) or Wistar-Furth (allograft) donor hearts will be transplanted into Lewis recipient rats. Isolated cytokine-stimulated cardiac myocytes(CM) will also be used. Gene expression will be determined by Western blot and RT-PCR. BH4 and NO synthesis will be determined by HPLC, NO analyzer or electron paramagnetic resonance (EPR) spectroscopy. Uncoupling of NO vs. superoxide production by varying co-factor synthesis (including GTP cyclohydrolase I overexpression), iNOS dimerization and nitrotyrosine formation will be examined by state-of-the-art biophysical and biochemical techniques including: get filtration with Western blot, immunohistochemistry, ELISA, EPR and fluorescence spectrosocpy, chemiluminescence. AIM#1: BH4 regulates NO production from iNOS in cytokine-activated CM and in CM after alloimmune activation. AIM #2: 6H4 regulates superoxide production from iNOS in cytokine-actived CM and in CM after alloimmune activation. AIM #3: Alteration in NO and superoxide production in cytokine-activated CM and in CM after alloimmune activation has downstream effects on biological markers of lipid peroxidation, protein oxidation and protein nitration. Findings from this study may provide unique strategies to protect against oxidate and nitrative injury in acute cardiac rejection. Public Health Statement: The loss of cardiac muscle cells is a significant problem in human cardiac transplants that may contribute to poor heart function. Our studies identify a potential molecular problem intrinsic to cardiac cells that predisposes to cell death and injury. A better understanding of this molecular process may lead to better strategies to prevent injury cardiac cells in these patients.
诱导型NO合成酶(iNOS)产生一氧化氮(NO)在炎症反应中起重要作用

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The complex role of iNOS in acutely rejecting cardiac transplants.
iNOS 在心脏移植急性排斥反应中的复杂作用。
  • DOI:
    10.1016/j.freeradbiomed.2008.01.020
  • 发表时间:
    2008
  • 期刊:
  • 影响因子:
    7.4
  • 作者:
    Pieper,GalenM;Roza,AllanM
  • 通讯作者:
    Roza,AllanM
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GALEN M PIEPER其他文献

GALEN M PIEPER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GALEN M PIEPER', 18)}}的其他基金

iNOS Posttranslational Regulation in Cardiac Rejection
心脏排斥反应中 iNOS 的翻译后调节
  • 批准号:
    7373617
  • 财政年份:
    2006
  • 资助金额:
    $ 36.78万
  • 项目类别:
iNOS Posttranslational Regulation in Cardiac Rejection
心脏排斥反应中 iNOS 的翻译后调节
  • 批准号:
    7195832
  • 财政年份:
    2006
  • 资助金额:
    $ 36.78万
  • 项目类别:
iNOS Posttranslational Regulation in Cardiac Rejection
心脏排斥反应中 iNOS 的翻译后调节
  • 批准号:
    7088167
  • 财政年份:
    2006
  • 资助金额:
    $ 36.78万
  • 项目类别:
MOLECULAR TARGETS OF NITRIC OXIDE IN CARDIAC TRANSPLANTS
心脏移植中一氧化氮的分子靶标
  • 批准号:
    6537767
  • 财政年份:
    2001
  • 资助金额:
    $ 36.78万
  • 项目类别:
MOLECULAR TARGETS OF NITRIC OXIDE IN CARDIAC TRANSPLANTS
心脏移植中一氧化氮的分子靶标
  • 批准号:
    6638613
  • 财政年份:
    2001
  • 资助金额:
    $ 36.78万
  • 项目类别:
MOLECULAR TARGETS OF NITRIC OXIDE IN CARDIAC TRANSPLANTS
心脏移植中一氧化氮的分子靶标
  • 批准号:
    6755178
  • 财政年份:
    2001
  • 资助金额:
    $ 36.78万
  • 项目类别:
MOLECULAR TARGETS OF NITRIC OXIDE IN CARDIAC TRANSPLANTS
心脏移植中一氧化氮的分子靶标
  • 批准号:
    6258634
  • 财政年份:
    2001
  • 资助金额:
    $ 36.78万
  • 项目类别:
PARAMAGNETIC COMPLEXES IN ALLOGENIC HETEROTROPIC CARDIAC TRANSPLANTS
同种异体异向性心脏移植中的顺磁性复合物
  • 批准号:
    6118848
  • 财政年份:
    1999
  • 资助金额:
    $ 36.78万
  • 项目类别:
DIABETES, TRANSPLANTATION AND VASCULAR ENDOTHELIUM
糖尿病、移植和血管内皮
  • 批准号:
    2223385
  • 财政年份:
    1993
  • 资助金额:
    $ 36.78万
  • 项目类别:
DIABETES, TRANSPLANTATION AND VASCULAR ENDOTHELIUM
糖尿病、移植和血管内皮
  • 批准号:
    2223386
  • 财政年份:
    1993
  • 资助金额:
    $ 36.78万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.78万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.78万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 36.78万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.78万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 36.78万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.78万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.78万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.78万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 36.78万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 36.78万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了